Roche
Roche launches $5.7 billion hostile bid for Illumina
January 25, 2012Research and Development, Sales and Marketing Diagnostics, Illumina, Roche
Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …
BMJ blasts Roche for withholding Tamiflu data
January 18, 2012Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO
Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …
Avastin now available in UK for ovarian cancer
January 17, 2012Sales and Marketing Cancer, Cancer Drugs Fund, NICE, Roche, avastin
Roche’s Avastin is now available as a treatment for women with ovarian cancer in the UK. Avastin (bevacizumab) can now …
Avastin gains EU licence for ovarian cancer
January 3, 2012Sales and Marketing Roche, avastin, ovarian
Roche’s Avastin has been granted a new European licence to treat ovarian cancer, which could help offset falling sales of …
EMA panel gives positive opinion for Roche’s Zelboraf
December 16, 2011Sales and Marketing EMA, Roche, Zelboraf
The EMA’s advisory committee is recommending the approval of Roche’s skin cancer drug Zelboraf. The European regulator’s Committee for Medicinal …
Merck and Roche begin combination hep C trial
December 16, 2011Research and Development, Sales and Marketing Copegus, Merck, Pegasys, Roche, Victrelis
Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …
Roche makes changes in its corporate executive committee
December 15, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Roche
Roche has made two new appointments in its corporate executive committee. Sophie Kornowski-Bonnet, currently general manager of Roche in France, …
NICE gives partial recommendation for RoActemra
December 14, 2011Sales and Marketing RoActemra, Roche
Roche’s patient access scheme has persuaded NICE to recommend RoActemra in childhood arthritis under certain circumstances. In its final guidance …
Roche’s new breast cancer drug succeeds in late-stage trial
December 9, 2011Research and Development, Sales and Marketing Roche, breast cancer, pertuzumab
Roche’s next generation breast cancer drug pertuzumab has helped patients to live over six months longer. CLEOPATRA, the first randomised …
Roche unveils Zurich translational partnership
December 7, 2011Research and Development Roche, Zurich, academic alliance, translational research
Roche has unveiled a new research collaboration with academic researchers and leading clinical centres in Switzerland. The Basel-based pharma company …
Roche’s Lung cancer test approved for Europe
December 5, 2011Research and Development, Sales and Marketing Roche, Tarceva, lung cancer
A new test which should help to better target treatment of patients with non-small cell lung cancer (NSCLC) has received …
Roche inks $490 million deal with PTC Therapeutics
November 30, 2011Research and Development, Sales and Marketing PTC Therapeutics, Roche
Roche has signed a $490 million deal with specialist biotech firm PTC Therapeutics. Roche is paying PTC $30 million upfront …
Roche opens $271m formulations centre
November 29, 2011Manufacturing and Production Roche, manufacturing
Roche has officially opened a 250 million Swiss franc ($271m) R&D centre in Switzerland that will be used to develop …
Lucentis rival gains US approval
November 22, 2011Research and Development, Sales and Marketing Bayer, Eylea, Lucentis, Novartis, Regeneron, Roche
A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …
FDA pulls Roche’s Avastin for breast cancer
November 21, 2011Research and Development, Sales and Marketing FDA, Roche, avastin
The FDA has pulled Avastin’s breast cancer licence in the US after the drug failed to prove its safety and …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
